All You'll Need to Know About Vioxx Clinical Trials
View the FDA Vioxx studies, clinical trials and other information on the drug Vioxx. For even more information, please fill out this simple form, call our client relations department at 1 (800) 476-6070, or email us at clientrelations@weitzlux.com.
| VIOXX Studies | |||||
| 1999 Vioxx Approved |
Study begins for Alzheimer's treatment, study for Alzhrimrt's prevention already in progress | Protocol for study finalized | Trial initiated | ||
| 2000 | Start of enrollment in study | Trial completed, results reported to the FDA | |||
| 2001 | Enrollment period ends | Study proposed | |||
| 2002 | Enrollment begins | FDA alters prescribing information | |||
| 2003 | Protocol for study finalized and enrollment begins | ||||
|
2004 |
Early termination of trial. Merck recalls Vioxx | Study terminated | Study terminated | Study terminated | |
If you or a loved one has suffered due to a side effect of Vioxx, you can fill out this simple form for a free case review within 24 hours.
Weitz & Luxenberg is no longer accepting Vioxx cases.
see also:
VIGOR
Might Vioxx affect your GI tract? Find answers from the VIGOR studyVIGOR - Merck's Clinical Trial determining Vioxx's affect on the GI
Alzheimer's Disease
Affected by Alzheimer’s Disease? Vioxx has been tested to helpWhat you should know about Alzheimer's Disease and Vioxx testing
Links & Numbers
Looking for something? All important Vioxx links and numbers are hereA compilation of necessary Links and Numbers all Vioxx users will need
